Synthetic Biologics (SYN) Reports In-Line Q2 EPS
Tweet
Share
E-mailSynthetic Biologics (NYSE: SYN) reported Q2 EPS of ($0.02), in-line with the analyst estimate of ($0.02).
Cash and cash equivalents as of June 30, 2021 totaled $74.3 million, an increase of $68.1 million from December 31, 2020.
For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
